Eli Lilly will acquire Merida Biosciences for up to $2.875 billion, gaining MER511, a Phase I therapy targeting ...

Amid proliferation of digital platforms for documentation and process execution, biopharma companies are exploring new ...

Large-scale validation of regenerative medicine, especially based on cell therapies, may come from cell therapies developed ...

Earlier this week, it was confirmed that a $380 million partnership between Bristol Myers Squibb (BMS) and contract ...

Dare To Use Preparative Chromatography at Industrial Scale for Your API: Maximize Purity, Efficiency, and Sustainability ...

Argentine biotech firm Biosidus tripled its cell culture capacity with a $12.9 million expansion to boost biosimilar ...

Genentech will invest $750 million in a fill-finish facility in Oregon, reached a construction milestone in North Carolina, ...

Industry expert Charley Maxwell shares essential strategies for biotech companies navigating Europe's fragmented regulatory ...

Bristol Myers Squibb subsidiary RayzeBio has committed to building a radiopharmaceutical manufacturing facility in Whitestown ...

An expert from CTMC told BioProcess International how recent projects in Houston speak to the city’s drive to become a ...

The CEO called the achievement a “major milestone” for his company’s global manufacturing strategy.

Sartorius unveils the Sartocon Q Hydrosart 30 kDa mAb cassette, designed to improve efficiency in high-concentration antibody ...